Home  »  Hot Stocks   »  Looking Closely at the Growth Curve for Physicians...

Looking Closely at the Growth Curve for Physicians Realty Trust (DOC)

Physicians Realty Trust (NYSE:DOC) went down by -2.06% from its latest closing price compared to the recent 1-year high of $19.12. The company’s stock price has collected 0.71% of gains in the last five trading sessions.

Is It Worth Investing in Physicians Realty Trust (NYSE :DOC) Right Now?

Physicians Realty Trust (NYSE:DOC) scored a price-to-earnings ratio above its average ratio, recording 26.80 x from its present earnings ratio. Plus, the 36-month beta value for DOC is at 0.75.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.


DOC currently public float of 226.19M and currently shorts hold a 4.74% ratio of that float. Today, the average trading volume of DOC was 1.59M shares.

DOC’s Market Performance

DOC stocks went up by 0.71% for the week, with a monthly drop of -2.67% and a quarterly performance of -18.96%, while its annual performance rate touched -21.55%. The volatility ratio for the week stands at 1.96% while the volatility levels for the past 30 days are set at 2.43% for Physicians Realty Trust. The simple moving average for the period of the last 20 days is -2.04% for DOC stocks with a simple moving average of -14.78% for the last 200 days.

Analysts’ Opinion of DOC

Many brokerage firms have already submitted their reports for DOC stocks, with JP Morgan repeating the rating for DOC by listing it as a “Neutral.” The predicted price for DOC in the upcoming period, according to JP Morgan is $17 based on the research report published on October 28th of the current year 2022.

Colliers Securities, on the other hand, stated in their research note that they expect to see DOC reach a price target of $19. The rating they have provided for DOC stocks is “Neutral” according to the report published on August 05th, 2022.

CapitalOne gave a rating of “Equal Weight” to DOC, setting the target price at $20 in the report published on June 03rd of the current year.

DOC Trading at -3.25% from the 50-Day Moving Average

After a stumble in the market that brought DOC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -25.58% of loss for the given period.

Volatility was left at 2.43%, however, over the last 30 days, the volatility rate increased by 1.96%, as shares sank -2.40% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -11.50% lower at present.

During the last 5 trading sessions, DOC rose by +0.71%, which changed the moving average for the period of 200-days by -16.59% in comparison to the 20-day moving average, which settled at $14.51. In addition, Physicians Realty Trust saw -24.43% in overturn over a single year, with a tendency to cut further losses.

Insider Trading

Reports are indicating that there were more than several insider trading activities at DOC starting from Thomas John T, who sale 10,000 shares at the price of $17.81 back on Aug 19. After this action, Thomas John T now owns 459,801 shares of Physicians Realty Trust, valued at $178,100 using the latest closing price.

Thomas John T, the President and CEO of Physicians Realty Trust, sale 10,000 shares at $18.08 during a trade that took place back on Aug 18, which means that Thomas John T is holding 469,801 shares at $180,800 based on the most recent closing price.

Stock Fundamentals for DOC

Equity return is now at value 4.30, with 2.30 for asset returns.

Is Twilio Inc. (TWLO) a Keeper?

Twilio Inc. (NYSE:TWLO) went down by -5.24% from its latest closing price compared to the recent 1-year high of $289.00. The company’s stock price has